Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-01-30

FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

SUPPL AP for LEVEMIR (INSULIN DETEMIR)